These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 5351142)
21. [Absent biological demonstration of "long-acting thyroid stimulator" (LATS) in endemic euthyroid iodine deficiency goiters]. Stelzer M; Mertz DP Munch Med Wochenschr; 1969 Jun; 111(23):1306-9. PubMed ID: 5820134 [No Abstract] [Full Text] [Related]
22. [The etiopathogenic role of long-acting thyroid stimulator in thyrotoxicosis]. Papazov G; Milanov S; Platonova E Vutr Boles; 1972; 11(2):59-62. PubMed ID: 4679953 [No Abstract] [Full Text] [Related]
23. Can LATS be detected by immunofluorescence? Beall GN; Solomon DH; Doniach D; Roitt IM J Clin Endocrinol Metab; 1969 Aug; 29(8):1114-6. PubMed ID: 4895860 [No Abstract] [Full Text] [Related]
24. Changes in LATS and other thyoid autoantibody levels with therapy. Kilpatrick JA N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201 [No Abstract] [Full Text] [Related]
25. The value of IgG separation for the detection of LATS in human serum. Bonnyns M; Vanhaelst L Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122 [TBL] [Abstract][Full Text] [Related]
26. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine]. Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759 [No Abstract] [Full Text] [Related]
27. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism]. Lamberg BA; Gordin A Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398 [No Abstract] [Full Text] [Related]
28. [Long-acting thyroid stimulator (LATS) in thyroid pathology]. Winand R Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466 [No Abstract] [Full Text] [Related]
29. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism]. Noguchi A; Kurihara H; Ozeki Y; Sato S Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106 [No Abstract] [Full Text] [Related]
30. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)]. Mertz DP; Stelzer M Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881 [No Abstract] [Full Text] [Related]
34. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases]. Depisch D; Höfer R; Schatz H Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238 [No Abstract] [Full Text] [Related]
35. [Immunologic problems in thyroid diseases]. Höfer R; Schatz H Z Gesamte Inn Med; 1969 Mar; 24(6):Suppl:91-6 c. PubMed ID: 5802036 [No Abstract] [Full Text] [Related]
36. Hyperthyroidism. Wool MS Major Probl Clin Surg; 1980; 15():102-19. PubMed ID: 7003266 [No Abstract] [Full Text] [Related]
37. Elevation of anti-DNA antibody titer during thyrotoxic phase of silent thyroiditis. Tajiri J; Higashi K; Morita M; Ohishi S; Umeda T; Sato T Arch Intern Med; 1986 Aug; 146(8):1623-4. PubMed ID: 3488044 [TBL] [Abstract][Full Text] [Related]
38. [Infrequent forms of hyperthyroidism]. Gasiorowski W Pol Tyg Lek; 1977 Jan; 32(4):163-5. PubMed ID: 834656 [No Abstract] [Full Text] [Related]
39. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease. Földes J; Takó J; Bános C; Gesztesi E; Varga I Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883 [No Abstract] [Full Text] [Related]